A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
- PMID: 32017379
- DOI: 10.1002/anie.201916400
A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
Abstract
PtII complexes are commonly used to treat cancer. To reduce their side effects and improve their pharmacological properties, PtIV complexes are being developed as prodrug candidates that are activated by reduction in cancer cells. Concomitantly, RuII polypyridine complexes have gained much attention as photosensitizers for use in photodynamic therapy due to their attractive characteristics. In this article, a novel PtIV -RuII conjugate, which combines cancer activated chemotherapy with PDT, is presented. Upon entering the cancer cell, the PtIV centre is reduced to PtII and the axial ligands including the RuII complex and phenylbutyrate are released. As each component has its individual targets, the conjugate exerts a multi-target and multi-action effect with (photo-)cytotoxicity values upon irradiation up to 595 nm in the low nanomolar range in various (drug resistant) 2D monolayer cancer cells and 3D multicellular tumour spheroids.
Keywords: bioinorganic chemistry; metals in medicine; photodynamic therapy; platinum prodrugs.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Biotin-Pt(IV)-Ru(II)-Boron-Dipyrromethene Prodrug as "Platin Bullet" for Targeted Chemo- and Photodynamic Therapy.Inorg Chem. 2024 Sep 16;63(37):17249-17262. doi: 10.1021/acs.inorgchem.4c03083. Epub 2024 Sep 5. Inorg Chem. 2024. PMID: 39235210
-
A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.Inorg Chem. 2018 Mar 5;57(5):2917-2924. doi: 10.1021/acs.inorgchem.8b00053. Epub 2018 Feb 13. Inorg Chem. 2018. PMID: 29436828
-
Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.Eur J Med Chem. 2024 Oct 5;276:116618. doi: 10.1016/j.ejmech.2024.116618. Epub 2024 Jun 28. Eur J Med Chem. 2024. PMID: 38972079
-
Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.Eur J Med Chem. 2021 Dec 5;225:113770. doi: 10.1016/j.ejmech.2021.113770. Epub 2021 Aug 11. Eur J Med Chem. 2021. PMID: 34403979 Review.
-
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.Drug Des Devel Ther. 2020 Dec 3;14:5375-5392. doi: 10.2147/DDDT.S275007. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33299303 Free PMC article. Review.
Cited by
-
Advances in photosensitizer-related design for photodynamic therapy.Asian J Pharm Sci. 2021 Nov;16(6):668-686. doi: 10.1016/j.ajps.2020.12.003. Epub 2021 May 2. Asian J Pharm Sci. 2021. PMID: 35027948 Free PMC article. Review.
-
Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action.Molecules. 2020 Nov 6;25(21):5167. doi: 10.3390/molecules25215167. Molecules. 2020. PMID: 33171980 Free PMC article. Review.
-
Ru(II) CONTAINING PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CRITIQUE ON REPORTING AND AN ATTEMPT TO COMPARE EFFICACY.Coord Chem Rev. 2022 Nov 1;470:214712. doi: 10.1016/j.ccr.2022.214712. Epub 2022 Jul 26. Coord Chem Rev. 2022. PMID: 36686369 Free PMC article.
-
Preparation of Composite Hydrogels Based on Cysteine-Silver Sol and Methylene Blue as Promising Systems for Anticancer Photodynamic Therapy.Gels. 2024 Sep 5;10(9):577. doi: 10.3390/gels10090577. Gels. 2024. PMID: 39330179 Free PMC article.
-
Selective Targeting of Regulated Rhabdomyosarcoma Cells by Trinuclear Ruthenium(II)-Arene Complexes.J Med Chem. 2024 Apr 25;67(8):6673-6686. doi: 10.1021/acs.jmedchem.4c00256. Epub 2024 Apr 3. J Med Chem. 2024. PMID: 38569098 Free PMC article.
References
-
- None
-
- A.-M. Florea, D. Büsselberg, Cancers 2011, 3, 1351-1371;
-
- C. Cullinane, G. B. Deacon, P. R. Drago, A. P. Erven, P. C. Junk, J. Luu, G. Meyer, S. Schmitz, I. Ott, J. Schur, L. K. Webster, A. Klein, Dalton Trans. 2018, 47, 1918-1932;
-
- Z. Wang, Z. Deng, G. Zhu, Dalton Trans. 2019, 48, 2536-2544;
-
- M. Hanif, C. G. Hartinger, Future Med. Chem. 2018, 10, 615-617;
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials